AU2001290309A1 - Method of diagnosing nephropathy - Google Patents

Method of diagnosing nephropathy

Info

Publication number
AU2001290309A1
AU2001290309A1 AU2001290309A AU9030901A AU2001290309A1 AU 2001290309 A1 AU2001290309 A1 AU 2001290309A1 AU 2001290309 A AU2001290309 A AU 2001290309A AU 9030901 A AU9030901 A AU 9030901A AU 2001290309 A1 AU2001290309 A1 AU 2001290309A1
Authority
AU
Australia
Prior art keywords
diagnosing nephropathy
nephropathy
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290309A
Other languages
English (en)
Inventor
Masanori Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex International Reagents Co Ltd
Original Assignee
International Reagents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Reagents Corp filed Critical International Reagents Corp
Publication of AU2001290309A1 publication Critical patent/AU2001290309A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001290309A 2000-10-27 2001-09-28 Method of diagnosing nephropathy Abandoned AU2001290309A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-329102 2000-10-27
JP2000329102 2000-10-27
PCT/JP2001/008512 WO2002037099A1 (fr) 2000-10-27 2001-09-28 Procede de diagnostic de la nephropathie

Publications (1)

Publication Number Publication Date
AU2001290309A1 true AU2001290309A1 (en) 2002-05-15

Family

ID=18805840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290309A Abandoned AU2001290309A1 (en) 2000-10-27 2001-09-28 Method of diagnosing nephropathy

Country Status (5)

Country Link
US (1) US6969591B2 (ja)
EP (1) EP1336845B1 (ja)
JP (1) JPWO2002037099A1 (ja)
AU (1) AU2001290309A1 (ja)
WO (1) WO2002037099A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100488281B1 (ko) 2001-09-15 2005-05-10 아람 바이오시스템 주식회사 열 대류를 이용한 염기서열 증폭 방법 및 장치
TWI233872B (en) * 2004-07-15 2005-06-11 New Sun Far East Corp Ltd Hand tool having warning function
US9000134B2 (en) * 2007-05-11 2015-04-07 Wallace B. Haigh Reagent and kit for early diagnosis of kidney disease
US20090104649A1 (en) * 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
US20090068683A1 (en) * 2007-06-11 2009-03-12 Mayo Foundation For Medical Education And Research Markers for preeclampsia
JP5515740B2 (ja) * 2007-09-27 2014-06-11 国立大学法人 新潟大学 尿中タンパク質定量用の尿前処理剤、尿前処理方法、及び尿中タンパク質定量方法。
JP5735411B2 (ja) * 2009-02-23 2015-06-17 プリマハム株式会社 イムノクロマト法によるアレルゲン検出方法
EP2442106B1 (en) * 2009-06-10 2015-08-19 Masanori Hara Method for test on diabetic nephropathy
EP2442105B1 (en) * 2009-06-10 2015-01-07 Niigata University Test method on renal diseases
AU2010339723B2 (en) 2009-12-21 2014-11-06 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-VEGF treatment
CN102791847B (zh) 2010-01-12 2015-01-21 阿赫姆生物系统公司 三阶段热对流装置及其用途
JP5865261B2 (ja) 2010-01-12 2016-02-17 アーラム バイオシステムズ インコーポレイテッド ２段熱対流装置及びその使用法
EP2541253B1 (en) * 2010-02-26 2016-10-12 Masanori Hara Test method for acute renal injury
US20130101578A1 (en) * 2010-04-12 2013-04-25 National University Of Singapore Biomarker for renal function in patients with type 2 diabetes
JP5866291B2 (ja) 2010-09-30 2016-02-17 積水メディカル株式会社 イムノクロマトグラフィー用テストストリップおよびその製造方法
EP2702998A1 (en) 2012-08-31 2014-03-05 IMBA-Institut für Molekulare Biotechnologie GmbH Therapeutic and diagnostic miRNA regulator in kidney disease
JP6091158B2 (ja) 2012-10-23 2017-03-08 デンカ生研株式会社 尿を変性剤で前処理することによる免疫測定系の感度を上げる方法
JP6310861B2 (ja) * 2012-12-26 2018-04-11 原　正則 尿中ポドサイトの検出方法
WO2014105837A1 (en) * 2012-12-28 2014-07-03 Beckman Coulter, Inc. Compositions for permeabilising fixed blood cells and uses thereof
JP6207002B2 (ja) 2013-02-19 2017-10-04 国立大学法人 筑波大学 尿中メガリン測定値から糸球体濾過量を推定する方法
WO2016046636A2 (en) 2014-09-05 2016-03-31 American University Of Beirut Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
EP3273241B1 (en) * 2015-03-17 2019-10-30 National Institute of Advanced Industrial Science and Technology Method and kit for detecting stem cell
WO2016171216A1 (ja) * 2015-04-22 2016-10-27 原正則 尿中ポドサイト数を推定する方法
WO2018177949A1 (en) * 2017-03-25 2018-10-04 Charité-Universitätsmedizin Berlin Urine flow cytometry as biomarker of renal diseases
CN113454457A (zh) * 2019-02-18 2021-09-28 株式会社Nb健康研究所 细胞的筛选方法、核酸的制造方法、重组细胞的制造方法、目标物质的制造方法、药物组合物的制造方法及试剂
JP6714256B1 (ja) 2019-12-18 2020-06-24 株式会社イムノセンス 電気化学法ラテラルフロー式免疫検査方法とそのセンサーおよびその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
DK0514928T3 (da) * 1991-05-24 1997-10-20 Wakamoto Pharma Co Ltd Fremgangsmåde til diagnosticering af nyresygdomme ved påvisning af albuminfragmenter
JP2932837B2 (ja) 1992-06-25 1999-08-09 富士レビオ株式会社 ヒトポドカリキシンの測定方法
US5534431A (en) * 1994-02-28 1996-07-09 The Board Of Regents Of The University Of Nebraska Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof
US5707818A (en) * 1994-12-13 1998-01-13 Bsi Corporation Device and method for simultaneously performing multiple competitive immunoassays
JP3870242B2 (ja) 1995-08-31 2007-01-17 生化学工業株式会社 腎疾患の検知法、診断薬及び診断用キット
US6673629B2 (en) * 1998-01-15 2004-01-06 Abbott Laboratories Neutralization of polycations in a chromatographic device for whole blood use
EP1053307A4 (en) * 1998-02-11 2002-10-31 Univ California SODALOMUCINS OF THE PODOCALYXIN TYPE HAVING SELECTIN LIGAND ACTIVITY
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
AU4169600A (en) 1999-03-02 2000-09-21 Biostratum, Inc. Method for the detection of congenital nephrotic syndrome

Also Published As

Publication number Publication date
EP1336845A1 (en) 2003-08-20
EP1336845A4 (en) 2006-06-07
US6969591B2 (en) 2005-11-29
WO2002037099A1 (fr) 2002-05-10
EP1336845B1 (en) 2013-03-27
US20040058395A1 (en) 2004-03-25
JPWO2002037099A1 (ja) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2001290309A1 (en) Method of diagnosing nephropathy
AU2001263887A1 (en) Monitoring method
AU2001276484A1 (en) Drilling method
AU2001268138A1 (en) Method of performing distributed load testing
AU2002220579A1 (en) Method of evaluating formation properties
AU2002222172A1 (en) Method of retrieving entities
AU2001238696A1 (en) Method of reducing defects
AU2001289827A1 (en) Continuous method of hydrogenation
AU2001276957A1 (en) Method of diagnosing pulmonary hypertension
AU2001281633A1 (en) Detection method
AUPQ667800A0 (en) Detection method
AU2001294258A1 (en) Method of purifying plavastatin
AU2001284578A1 (en) Toilet block
AU2001246964A1 (en) Method of manufacturing hydrogen
AU2001290313A1 (en) Service providing method
AU2001271032A1 (en) Means of examining nephropathy
AU2001237530A1 (en) Method
AU2002341150A1 (en) Method
AU2002216479A1 (en) Isolation method
AU2002309621A1 (en) Predictive method
AU2001241636A1 (en) Halotherapy method
AU2002222927A1 (en) Method of making hydrofluorocarbons
AU2001271220A1 (en) Body-cavity probe and method
AU2001290731A1 (en) Structural prediction of allosterism
GB0024938D0 (en) Method of diagnosis